SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,411.16 -317.00
( -0.41%)

Global Indices

Nasdaq

53,489.46 -263.95
(-0.49%)

Dow Jones

7,767.06 -39.70
(-0.51%)

Hang Seng

69,148.70 434.90
(0.63%)

Nikkei 225

10,727.81 -22.30
(-0.21%)

Forex

USD-INR

95.53 0.14
(0.14%)

EUR-INR

110.53 0.55
(0.50%)

GBP-INR

129.27 0.59
(0.46%)

JPY-INR

0.60 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

163.1433353

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FREDUN

54.09

2403.56

EPS(TTM)

Face Value()

Div & Yield %

26.87

0.02

Back

Fredun Pharmaceuticals consolidated net profit rises 93.94% in the June 2026 quarter

Aug 05,2026

Net profit of Fredun Pharmaceuticals rose 93.94% to Rs 13.13 crore in the quarter ended June 2026 as against Rs 6.77 crore during the previous quarter ended June 2025. Sales rose 90.75% to Rs 227.76 crore in the quarter ended June 2026 as against Rs 119.40 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	227.76	119.40	91
OPM %	14.37	14.23	-
PBDT	24.12	10.46	131
PBT	20.55	9.04	127
NP	13.13	6.77	94

77,411.16 -317.00 ( -0.41%)

53,489.46 -263.95 (-0.49%)

7,767.06 -39.70 (-0.51%)

69,148.70 434.90 (0.63%)

10,727.81 -22.30 (-0.21%)

95.53 0.14 (0.14%)

110.53 0.55 (0.50%)

129.27 0.59 (0.46%)

0.60 0.00 (0.19%)